WallStSmart
AGEN

Agenus Inc

NASDAQ: AGEN · HEALTHCARE · BIOTECHNOLOGY

$3.84
-1.29% today

Updated 2026-04-29

Market cap
$147.45M
P/E ratio
0.00
P/S ratio
1.29x
EPS (TTM)
$0.00
Dividend yield
52W range
$3 – $7
Volume
0.8M

Agenus Inc (AGEN) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+50.1%
Last 4 quarters
Revenue YoY growth
+27.5%
Most recent quarter
EPS YoY growth
+133.4%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+18.0%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+28.7%
2026-03-16
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-16$0.68+152.4%$3.10$3.99+28.7%
2025-11-10$1.94+792.9%$3.98$4.27+7.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-1.30$0.68+152.4%$34.20M+27.5%
2025-09-30$-0.28$1.94+792.9%$30.23M+20.4%
2025-06-30$-0.27$-1.00-270.4%$25.69M+9.3%
2025-03-31$-1.98$-1.03+48.0%$24.07M-14.1%
2024-12-31$-2.54$-2.04+19.7%$26.84M-68.0%
2024-09-30$-2.33$-3.08-32.2%$25.11M+3.3%
2024-06-30$-1.44$-2.52-75.0%$23.51M-7.1%
2024-03-31$-3.22$-3.04+5.6%$28.00M+22.3%
2023-12-31$-0.05$-0.13-160.0%$83.80M
2023-09-30$-0.19$-0.16+15.8%$24.31M
2023-06-30$-0.20$-0.20+0.0%$25.30M
2023-03-31$-0.21$-0.22-4.8%$22.90M

Frequently asked questions

Has Agenus Inc beaten earnings estimates?
Agenus Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +50.1% over the last 4 quarters.
How does AGEN stock react to earnings?
AGEN stock has moved an average of +18.0% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Agenus Inc's revenue growth rate?
Agenus Inc reported year-over-year revenue growth of +27.5% in its most recent quarter, with EPS growing +133.4% year-over-year.